Retatrutide 30mg

Retatrutide is what scientists call a “triple agonist.” and it is a single peptide chain consisting of 39 amino acids.

Its backbone is primarily derived from the native human GIP (Glucose-dependent Insulinotropic Polypeptide) structure, but it has been heavily modified with specific substitutions to allow it to cross-react with GLP-1 and Glucagon receptors.

Retatrutide is primarily being developed as a next-generation treatment for chronic weight management (obesity) and Type 2 diabetes.

However, because of how it interacts with the body’s metabolism, researchers are also studying its effects on several related conditions:

• Fatty Liver Disease (specifically MASH/NASH)
• Cardiovascular and Kidney Disease risk reduction
• Sleep Apnea
• Knee Osteoarthritis (reducing joint pain caused by excess weight)

THIS PRODUCT IS INTENDED FOR IN VITRO LABORATORY RESEARCH AND DEVELOPMENT USE ONLY